Professional Documents
Culture Documents
แนวปฏิบัติการจัดการของเสียทางการแพทย์ที่เป็นสารเคมี, มีนาคม 2559
แนวปฏิบัติการจัดการของเสียทางการแพทย์ที่เป็นสารเคมี, มีนาคม 2559
indd 1
12/7/59 10:07
ISBN : 978-974-244-375-7
:
:
88/24 11000
02 590 7289, 02 591 8278
02 590 7287
ipcs_fda@fda.moph.go.th
http://ipcs.fda.moph.go.th/csnetNEW/
1 : 2559
:
.. .. 2554
E-Book FULL.indd 2
12/7/59 10:07
III
21
3 (1) /
(2) (3)
2559
E-Book FULL.indd 3
12/7/59 10:07
IV
III
IV
1
1
/ 2
(Pharmaceutical waste)
(I) 5
(II) 9
13
14
29
E-Book FULL.indd 4
12/7/59 10:07
()
2
(Laboratory waste)
33
3
(Heavy metal in medical device)
51
E-Book FULL.indd 5
34
40
49
50
51
52
52
53
54
62
12/7/59 10:07
CI
E-Book FULL.indd 6
12/7/59 10:07
//
/ (Pharmaceutical waste)
(Laboratory waste)
E-Book FULL.indd 1
12/7/59 10:07
/
(Pharmaceutical waste)
4000
10
71
600
E-Book FULL.indd 2
25
WHO (2012)
25
12/7/59 10:07
U.S. FDA
Pregnancy Category X
Avoid/Reduce
Reuse
Recycle
Waste to
energy
Disposal
of waste
E-Book FULL.indd 3
/
(Waste Minimization)
/
12/7/59 10:07
/
2
1.
2.
E-Book FULL.indd 4
12/7/59 10:07
(I)
/
(endocrine disruptor)
1
(pregnancy category X)
(chemotherapy)
(immunosuppressive)
E-Book FULL.indd 5
12/7/59 10:07
1200 C (
)
(lined hazardous
waste landfill)
Lined Hazardous Waste Landfill
>1200 C
Tuberculosis (BCG)
Landfill
850 C
( )
(Landfill
)
> 850 C
850 C (
)
(witnessed destruction)
> 850 C
E-Book FULL.indd 6
Landfill
12/7/59 10:07
7
4
850 C ( )
Landfill
> 850 C
1 1
Hazardous
Waste Incinerator
> 1200
Autoclave
Medical Waste
Incinerator
> 850
1 /
( Presentation Pharmaceutical waste management Massoomi, 2011)
E-Book FULL.indd 7
12/7/59 10:07
1 /
* /
()
()
()
()
800-1000 o C
E-Book FULL.indd 8
12/7/59 10:07
(II)
/
. .
(1)
(2)
()
(
)
() ()
E-Book FULL.indd 9
12/7/59 10:07
10
(II) ()
(.)
(chemotherapy)
(antibiotic) (antiviral drug)
(hormone)
(endrocrine disruptor)
(toxic to reproductive system)
(pregnancy category X)
(immunosuppressive)
E-Book FULL.indd 10
12/7/59 10:07
11
2
2 /
- /
- ()
800-1000 o C
( )
E-Book FULL.indd 11
12/7/59 10:07
12
2 /
( )
E-Book FULL.indd 12
12/7/59 10:07
13
Charlotte A. Smith (2002). Managing Pharmaceutical Waste- What pharmacists should know.
Journal of the Pharmacy Society of Wisconsin. Madison, WI: Pharmacy Society of Wisconsin.
FDA (Food and Drug Administration) (2011). How to Dispose of Unused Medicines.
FDA Consumer Health Information. Washington, D.C.: FDA.
NIOSH (National Institute for Occupational Safety and Health) (2004). NIOSH Alert:
Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health
Care Settings. Cincinnati, OH: NIOSH.
NIOSH (2012). NIOSH List of Antineoplastic and Other Hazardous Drug in Healthcare
Setting. Cincinnati, OH: NIOSH.
NIOSH (2014). NIOSH List of Antineoplastic and Other Hazardous Drug in Healthcare
Setting (update). Cincinnati, OH: NIOSH.
Practice Greenhealth and U.S. EPA (2008). Managing Pharmaceutical Waste : A 10 Step
Blueprint for Healthcare Facilities in the United States. Reston, Virginia: Practice Greenhealth.
U.S. EPA (United States Environmental Protection Agency) (1976). The Resource Conservation
and Recovery Act (RCRA).
FDA (2013). Medicines Recommended for Disposal by Flushing. Washington, D.C.: FDA.
UNEP (United Nations Environment Programme) and WHO (2013). State of the Science of
Endocrine Disrupting Chemicals 2012 Summary for Decision-Makers. Geneva: UNEP and WHO.
E-Book FULL.indd 13
12/7/59 10:07
14
/
(Pharmaceutical Waste)
Oral LD50
50
E-Book FULL.indd 14
12/7/59 10:07
15
2. U.S.CDC/ NIOSH /
hazardous pharmaceutical waste
2.1 (Chemotherapy) 2
2.1.1 Trace chemotherapy waste
3%
2.1.2 Hazardous chemotherapy waste
3% hazardous chemotherapy waste
2.2 (Endocrine disruptor)
estrogen derivatives
2.3 (Pregnancy category X)
2.4 (Antibiotic)
2.5 oral LD50 50 mg/kg BW.
2.6 U.S. National Institute of Occupational Safety and Health (NIOSH) CDC
hazardous drug (chemotherapy) (antiviral drug)
(hormone) (immunosuppressive)
- (carcinogenicity)
- (genotoxicity)
- (teratogenicity)/ (developmental toxicity)
- (reproductive toxicity)
- (organ toxicity at low doses)
- hazardous drug
NIOSH
http://www.cdc.gov/niosh/topics/hazdrug/default.html
1 2
1200 C
(lined hazardous waste landfill)
3. Controlled substance
U.S. Drug Enforcement Administration (DEA)
(witnessed destruction)
3
850 C
E-Book FULL.indd 15
12/7/59 10:07
16
EPA
(Chemotherapy)
NIOSH Preg.
X
Abiraterone acetate
Antineoplastic
Aldesleukin
Antineoplastic
Altretamine
Amsacrine
Anastrozole
Arsenic trioxide
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Asparaginase
Azacitidine
Antineoplastic
Antineoplastic
Bendamustine HCI
Antineoplastic
Bevacizumab Antineoplastic
(Monoclonal antibody)
Bexarotene
Antineoplastic
Bicalutamide
Antineoplastic
Bleomycin
Antineoplastic
Bortezomib
Antineoplastic
Brentuximab vedotin Antineoplastic
(Antibody-drug conjugate)
Busulfan
Cabazitaxel
E-Book FULL.indd 16
Antineoplastic
Antineoplastic
12/7/59 10:07
17
EPA
NIOSH Preg.
X
Capecitabine
Antineoplastic
Carboplatin
Antineoplastic
Carmustine
Antineoplastic
Chlorambucil
Cisplatin
Cladribine
Clofarabine
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Crizotinib
Cyclophosphamide
Antineoplastic
Antineoplastic
Cytarabine
Dacarbazine
Dactinomycin
Antineoplastic
Antineoplastic
Antineoplastic
Dasatinib
Daunorubicin HCI
Decitabine
Degarelix
Denileukin
Docetaxel
Doxorubicin
Epirubicin
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
E-Book FULL.indd 17
12/7/59 10:07
18
EPA
NIOSH Preg.
X
Eribulin mesylate
Antineoplastic
Erlotinib
Antineoplastic
Estramustine phosphate
Antineoplastic
Etoposide
Everolimus
Exemestane
Floxuridine
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Fludarabine
Fluorouracil
Antineoplastic
Antineoplastic
Flutamide
Fulvestrant
Gemcitabine
Antineoplastic
Antineoplastic
Antineoplastic
Gemtuzumab ozogamicin
Goserelin
Hydroxyurea
Idarubicin
Ifosfamide
Imatinib mesylate
Irinotecan HCI
Ixabepilone
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
E-Book FULL.indd 18
12/7/59 10:07
19
EPA
NIOSH Preg.
X
Letrozole
Antineoplastic
Leuprolide acetate
Antineoplastic
Lomustine
Antineoplastic
Mechlorethamine
Megestrol
Melphalan
Mercaptopurine
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Methotrexate
Mitomycin
Antineoplastic
Antineoplastic
Mitotane
Mitoxantrone HCI
Nelarabine
Antineoplastic
Antineoplastic
Antineoplastic
Nilotinib
Nilutamide
Oxaliplatin
Paclitaxel
Pazopanib HCI
Pegaspargase
Pemetrexed
Pentostatin
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
E-Book FULL.indd 19
12/7/59 10:07
20
EPA
NIOSH Preg.
X
Pipobroman
Antineoplastic
Pralatrexate
Antineoplastic
Procarbazine
Antineoplastic
Romidepsin
Sorafenib
Streptozocin
Sunitinib malate
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Tamoxifen
Temozolomide
Antineoplastic
Antineoplastic
Temsirolimus
Teniposide
Testolactone
Antineoplastic
Antineoplastic
Antineoplastic
Thioguanine
Thiotepa
Topotecan
Toremifene citrate
Triptorelin
Uracil mustard
Valrubicin
Vandetanib
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
Antineoplastic
E-Book FULL.indd 20
12/7/59 10:07
21
EPA
NIOSH Preg.
X
Vemurafenib
Antineoplastic
Vinblastine sulfate
Antineoplastic
Vincristine sulfate
Antineoplastic
Vinorelbine tartrate
Vorinostat
Antineoplastic
Antineoplastic
Chloramphenicol
Antibiotic
Televancin
Tetracycline HCI
Bactericidal
Antibiotic
(Antibiotic)
(Antiviral)
Abacavir
Cidofovir
Entecavir
Ganciclovir
Nevirapine
Ribavirin
Trifluridine
Valganciclovir
Vidarabine
Zidovudine
E-Book FULL.indd 21
Antiviral
Antiviral
Antiviral
Antiviral
Antiviral
Antiviral
Antiviral
Antiviral
Antiviral
Antiretroviral
12/7/59 10:07
22
EPA
NIOSH Preg.
X
(Antifungal)
Fluconazole
Antifungal
Voriconazole
Antifungal
(Antiprotozoal)
Pentamidine isethionate
Antiprotozoal
(Hormone)
Cetrorelix acetate
Gonadotropin-releasing
hormone antagonist
Choriogonadotropin alfa
Diethylstilbestrol (DES)
Estradiol
Estrogen-progestin combinations
Estrogen, conjugated
Gonadotropins
Synthetic Estrogen
Estrogen
Contraceptive
Estrogen
Ganirelix acetate
Gonadotropin-releasing
hormone antagonist
Gonadotropin, chorionic
Medroxyprogesterone acetate
Estrogens, esterified
Estrone
Estropipate
Fluoxymesterone
E-Book FULL.indd 22
Estrogen
Estrogen
Estrogen
Androgen
Gonadotropin
Progestin
12/7/59 10:07
23
EPA
NIOSH Preg.
X
Gonadotropin
Androgen
Gonadotropin
Progesterone
Progestins
Progestins
Contraceptive
Propylthiouracil
Antithyroid
Raloxifene Estrogen
agonist-antagonist
Tesamorelin acetate
Testosterone
Contraceptive
Menotropins
Methyltestosterone
Nafarelin
Ulipristal acetate
Alefacept
Immunosuppressant
Azathioprine
Immunosuppressant
Cyclosporin
Immunosuppressant
Fingolimod
Biological response
modulator
Leflunomide Antirheumatic
(immunosuppressant)
Lenalidomide
Biologic response
modifier
E-Book FULL.indd 23
12/7/59 10:07
24
EPA
NIOSH Preg.
X
Mycophenolate mofetil
Immunosuppressant
Mycophenolic acid
Immunosuppressant
Sirolimus
Immunosuppressant
Tacrolimus
Immunosuppressant
Thalidomide
Biologic response
modifier
(Anticonvulsant)
Carbamazepine
Clonazepam
Ezogabine
Oxcarbazepine
Topiramate
Valproic acid/divalproex Na
Vigabatrin
Zonisamide
Anticonvulsant
Anticonvulsant, sedative
Anticonvulsant
Anticonavulsant
Anticonvulsant
Anticonvulsant
Anticonvulsant
Anticonvulsant
/ (Chelator)
Deferiprone
FE chelator
Dexrazoxane
Chelator
Pentetate calcium Chelating agent
trisodium(Ca-DTPA)
(for removing radioactives)
E-Book FULL.indd 24
12/7/59 10:07
25
EPA
NIOSH Preg.
X
Physostigmine
Acholinergenic
Physostigmine salicylate
Acholinergenic
Resorcinol
Dronedarone HCI
Warfarin
Paroxetine
Antidiabetic
Antigout
Ambrisentan
Antihypertensive,
Vasodilating agent
Bosentan
Antihypertensive,
Vasodilating agent
Liraglutide recombinant
Colchicine
Phenoxybenzamine HCl
Antihypertensive,
Non-selective
alpha-adrenergic
blocking agent
Reserpine
Antihypertensive,
antipsychotic
Rasagiline mesylate
Risperidone
E-Book FULL.indd 25
Antiparkinson
Antipsychotic
12/7/59 10:07
26
Ziprasidone HCI
EPA
Antipsychotic
Mercury Antiseptic
(mercurochrome)
Device (thermometer,
sphygmomanometer)
Preservative
(thimerosal in vaccine)
NIOSH Preg.
X
Phenol
Antiseptic, anesthetic,
antipruritic
Phentermine
Appetite suppressant
(Controlled substance)
Zoledronic acid
Bone resorption inhibitor
Icatibant Bradykinin B 2
receptor antagonist
Palifermin
Cell stimulants
and proliferant
Chloral hydrate
(Controlled substance)
Cough syrup,
sleeping pill
Diuretic
Spironolactone
Apomorphine
E-Book FULL.indd 26
Dopamine agonist
12/7/59 10:07
27
EPA
NIOSH Preg.
X
Plerixafor
Hematopoietic agent
Cadmium
Multiple mineral
preparations
M-cresol
Preservative in human
insulin
Dinoprostrone
Oxytocic
Ergonovine/methylergonovine
Oxytocic
Mifepristone
Oxytocin
Barium sulfate
Oxytocic
Oxytocic
Radiopaque agent
Lindane
Hexachlorophene
Scabicide
Skin disinfectant
E-Book FULL.indd 27
12/7/59 10:07
28
EPA
Dexmedetomidine
Sedative
Paraldehyde
Sedative
(Controlled substance)
Selenium
Shampoo (anti-dandruff)
Multiple mineral
preparations
NIOSH Preg.
X
Podophyllum resin
Skin and mucous
membrane agent
(Cytotoxic)
Podofilox
Skin and mucous
membrane agent
(antimitotic)
Alitretinoin
Nicotine
Smoking cessation
Misoprostol
Stomach ulcers
treatment
Trichloromonofluoromethane
Topical anesthetic
Acitretin
E-Book FULL.indd 28
Vitamin A
12/7/59 10:07
29
E-Book FULL.indd 29
12/7/59 10:07
30
E-Book FULL.indd 30
12/7/59 10:07
31
E-Book FULL.indd 31
12/7/59 10:07
32
E-Book FULL.indd 32
12/7/59 10:07
33
(Laboratory waste)
CI
(solvent)
E-Book FULL.indd 33
12/7/59 10:07
34
1
(SDS)
4
4
2 //
Polypropylene (PP) Polyethylene (PE)
Hydrofluoric acid
( ether, dichloromethane,
)
High density polyethylene (HDPE)
E-Book FULL.indd 34
12/7/59 10:07
35
1
parafilm
(secondary containment)
2
3
3 4
(secondary containment)
E-Book FULL.indd 35
12/7/59 10:07
36
E-Book FULL.indd 36
12/7/59 10:07
37
4
5
E-Book FULL.indd 37
12/7/59 10:07
38
6 /
E-Book FULL.indd 38
12/7/59 10:07
39
Hydrogen peroxide
Copper, chromium, iron 5
LD50 50
E-Book FULL.indd 39
12/7/59 10:07
40
5
()
Acetic acid
Acetone
Acetylene
Ammonia (anhydrous)
Ammonium nitrate
Aniline
Arsenical materials
Azides
Reducing agents
Bromine
Chlorine
Calcium oxide
Water
Carbon (activated)
Carbon tetrachloride
E-Book FULL.indd 40
Acids
12/7/59 10:07
41
5
() ()
Chlorine
Chlorine dioxide
Chromic acid and
chromium
Copper
Cumene hydroperoxide
Cyanides
Flammable liquids
Fluorine
Hydrocarbons
( butane, propane,
benzene)
Hydrocyanic acid
Hydrofluoric acid
(anhydrous)
Hydrogen peroxide
E-Book FULL.indd 41
12/7/59 10:07
42
5
() ()
Hydrogen sulfide
Hypochlorites
Iodine
Mercury
Nitrates
Nitric acid (concentrated)
Nitrites
Nitroparaffins
Oxalic acid
Oxygen
Perchloric acid
Peroxides, organic
Phosphorus (white)
Phosphorus pentoxide
Potassium
Potassium chlorate
Potassium perchlorate
Potassium permanganate
Selenides
Silver
E-Book FULL.indd 42
Fuming nitric acid, oxidizing gases
Acids, activated carbon
Acetylene, ammonia (aqueous anhydrous), hydrogen
Acetylene, fulminic acid, ammonia
Sulfuric acid
Acetic acid, aniline, chromic acid, hydrocyanic acid,
hydrogen sulfide, flammable liquids, flammable gases,
copper, brass, any heavy metals
Potassium cyanide sodium cyanide.
Inorganic bases, amines
Silver, mercury
Oils, grease, hydrogen, flammable: liquids, solids, gases
Acetic anhydride, bismuth and its alloys, alcohol, paper,
wood, grease, oils
Acids (organic mineral)
Air, oxygen, alkalis, reducing agents
Water
Carbon tetrachloride, carbon dioxide, water
Sulfuric and other acids
Sulfuric, other acids chlorates
Glycerol, ethylene glycol, benzaldehyde, sulfuric acid
Reducing agents
Acetylene, oxalic acid, tartaric acid, ammonium compounds,
fulminic acid
12/7/59 10:07
43
5
() ()
Sodium
Sodium chlorate
Sodium nitrite
Sodium peroxide
Sulfides
Sulfuric acid
Tellurides
Reducing agents
Water ()
E-Book FULL.indd 43
12/7/59 10:07
44
1200 C
( )
(lined hazardous waste landfill)
>1200 C
Barium
Sulfate, Iodine Contrast
6
SDS
E-Book FULL.indd 44
12/7/59 10:07
45
Personal Protective Equipment
(PPE) /
E-Book FULL.indd 45
12/7/59 10:07
46
A
B
A1 A2 A3 A4 B1 B2 B3
Acetic acid
Ammonia
Barium sulfate
Chlorhexidine
gluconate
70% Ethanol
Fixer + Developer
x-ray
10 % Formalin
buffer 3.7%
Formaldehyde
Glutaradehyde
(working solution :
)
Iodophor
(Iodine + HCl)
Hydrochloric acid
3-5 % Hydrogen
Peroxide
E-Book FULL.indd 46
Fixer
(Ag)
12/7/59 10:07
47
6
()
A
B
A1 A2 A3 A4 B1 B2 B3
Iodine contrast
Mercury
Methanol
Lysol Cresol
(working solution)
Povidone Iodine
Solution
Sodalime
Sodium
hypochlorite
(working solution)
Sodium hydroxide
Sevoflurane
Trichloroacetic
acid
Toluene
Xylene
E-Book FULL.indd 47
12/7/59 10:07
48
6
()
A
B
A1 A2 A3 A4 B1 B2 B3
A1 1 /
A2 1 /
A3
A4 9 25% 1
24
B1 HDPE
B2 HDPE
B3 recycle
E-Book FULL.indd 48
12/7/59 10:07
49
,
(2547). .
: .
, ,
(2549).
(Chemical Safety for Medical Laboratory). : .
National Research Council (1995). Prudent practices in the laboratory. Washington,
D.C. : National Academies Press.
University of Cambridge, Occupational Health and Safety Service (2012). Chemical
Safety Guidance: Disposal of Chemical and Laboratory Waste Including the Zero to Drains
Policy. Cambridge: University of Cambridge.
E-Book FULL.indd 49
, ,
(2555).
. : .
12/7/59 10:07
50
1.
2
(flash point) 93.4 C
24 benzene, toluene, xylene, acetone kerosene
sodium metal
phosphorus
carbon, sulfur, aluminum metal
2.
sulfuric acid,
hydrochloric acid, nitric acid
3.
alkyl magnesium
halides n-butyllithium
sodium metal
potassium chlorate aluminum powder
calcium carbide sodium amide
potassium cyanide ferrous sulfide
ammonium
nitrate nitrocellulose
4.
Parathion-methyl
Benzene, Chloroform, Formaldehyde, Ethylene oxide
Ethidium bromide
Lead, Toluene
E-Book FULL.indd 50
12/7/59 10:07
51
(Heavy metal in medical device)
1 /
2
(
)
E-Book FULL.indd 51
12/7/59 10:07
52
(Heavy metal in medical device)
2
(alloy)
(trituration)
2 alloy tablet
Precapsulated alloy
3.1
( )
()
E-Book FULL.indd 52
12/7/59 10:07
53
3.2
3.3
MRI
(2558). .
: .
E-Book FULL.indd 53
12/7/59 10:07
54
E-Book FULL.indd 54
12/7/59 10:08
55
E-Book FULL.indd 55
12/7/59 10:08
56
E-Book FULL.indd 56
12/7/59 10:08
57
E-Book FULL.indd 57
12/7/59 10:08
58
E-Book FULL.indd 58
12/7/59 10:08
59
E-Book FULL.indd 59
12/7/59 10:08
60
E-Book FULL.indd 60
12/7/59 10:08
61
E-Book FULL.indd 61
12/7/59 10:08
62
E-Book FULL.indd 62
12/7/59 10:08
63
E-Book FULL.indd 63
12/7/59 10:08
64
E-Book FULL.indd 64
12/7/59 10:08
65
E-Book FULL.indd 65
12/7/59 10:08
66
E-Book FULL.indd 66
12/7/59 10:08
67
E-Book FULL.indd 67
12/7/59 10:08
..
..
17
E-Book FULL.indd 68
12/7/59 10:08